Skip to main content

Sievers Eric's Form 4 filing

BioAtla, Inc. (BCAB) · filed Dec 7, 2021

Accession no.
0001209191-21-068384
Filed
Dec 7, 2021
Trade date
Nov 30-Dec 2, 2021
Filing delay
7 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $25.0K. It was filed 7 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sievers EricCIK 0001835116Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 30, 2021Common StockSSaleDisposed−53$24.00−$1,27292,577Direct
Nov 30, 2021Common StockSSaleDisposed−58$24.68−$1,431.4492,519Direct
Nov 30, 2021Common StockSSaleDisposed−20$25.38−$507.692,499Direct
Dec 1, 2021Common StockSSaleDisposed−56$22.19−$1,242.6492,443Direct
Dec 1, 2021Common StockSSaleDisposed−96$23.27−$2,233.9292,347Direct
Dec 1, 2021Common StockSSaleDisposed−21$24.22−$508.6292,326Direct
Dec 2, 2021Common StockSSaleDisposed−804$21.74−$17,478.9691,522Direct
Dec 2, 2021Common StockSSaleDisposed−16$22.47−$359.5291,506Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)